Beclometasone/ formoterol/ glycopyrronium pMDI for maintenance treatment of moderate to severe COPD

Description

In this Product Explainer, Dr Philip Lee explains the role of beclomethasone/ formoterol/ glycopyrronium pressurised metered dose inhalers (pMDIs) for maintenance treatment of adults with moderate to severe COPD who are not adequately treated by ICS/LABA or LABA/LAMA (7 mins).

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
A/Prof Li-Chuen Wong

A/Prof Li-Chuen Wong

Eczema Practical Updates for General Practice

Dr Preeti Joshi

Dr Preeti Joshi

Cow’s Milk Allergy in Infants and Children

A/Prof Michael Woodward AM

A/Prof Michael Woodward AM

Arexvy is on the NIP – What You Need to Know

Clinical A/Prof Greg Katsoulotos

Clinical A/Prof Greg Katsoulotos

Inhaler Devices Workshop

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Dr Philip Lee

expert

Dr Philip Lee

Respiratory and Sleep Physician; Consultant, Respiratory and Sleep Medicine, St George and Northern Beaches Hospitals

Date published: 14 August 2024